These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Alleviation of ocular complications of the hyperviscosity syndrome in Waldenström's macroglobulinemia using plasma exchange]. Malecaze F; Mathis A; Gonzales C; Lloveras JJ; Goudable C; Arlet P; Bec P J Fr Ophtalmol; 1986; 9(5):367-71. PubMed ID: 3100607 [TBL] [Abstract][Full Text] [Related]
4. Role of plasmapheresis in Waldenström's macroglobulinemia. Stone MJ; Bogen SA Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):238-40. PubMed ID: 23522642 [TBL] [Abstract][Full Text] [Related]
5. [Hyperviscosity syndrome and Waldenström's macroglobulinemia]. Shida M; Baba M; Sawada S Nihon Rinsho; 1992 Jan; 50 Suppl():298-303. PubMed ID: 1578695 [No Abstract] [Full Text] [Related]
6. Effect of plasmapheresis on hyperviscosity-related retinopathy and retinal hemodynamics in patients with Waldenstrom's macroglobulinemia. Menke MN; Feke GT; McMeel JW; Treon SP Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1157-60. PubMed ID: 18326744 [TBL] [Abstract][Full Text] [Related]
7. Ophthalmologic techniques to assess the severity of hyperviscosity syndrome and the effect of plasmapheresis in patients with Waldenström's macroglobulinemia. Menke MN; Feke GT; McMeel JW; Treon SP Clin Lymphoma Myeloma; 2009 Mar; 9(1):100-3. PubMed ID: 19362987 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of therapeutic procedure for Waldenström's macroglobulinemia with hyperviscosity syndrome. Ito K; Kawasaki T; Hirano K; Sekiguchi N Ther Apher Dial; 2024 Jun; 28(3):417-423. PubMed ID: 38069574 [TBL] [Abstract][Full Text] [Related]
9. Plasmapheresis in hyperviscosity syndrome. Avnstorp C; Nielsen H; Drachmann O; Hippe E Acta Med Scand; 1985; 217(1):133-7. PubMed ID: 3919530 [TBL] [Abstract][Full Text] [Related]
10. [Effect of intensive plasmapheresis on the "syndrome of increased viscosity" and blood coagulation system in Waldenstrom's macroglobulinemia]. Mokeeva RA; Zhuravlev VS Probl Gematol Pereliv Krovi; 1969 Mar; 14(3):8-16. PubMed ID: 4981700 [No Abstract] [Full Text] [Related]
11. [Plasmapheresis and hyperviscosity syndrome]. Corral Alonso M; Barbolla ML Sangre (Barc); 1984; 29(5):940-50. PubMed ID: 6441295 [No Abstract] [Full Text] [Related]
12. [Waldenström's macroglobulinemia: clinical aspects, diagnosis and therapy]. Baldus M; Brass H Med Klin (Munich); 1992 Aug; 87(8):434-6. PubMed ID: 1406477 [No Abstract] [Full Text] [Related]
13. Hyperviscosity in plasma cell dyscrasias. Kwaan HC Clin Hemorheol Microcirc; 2013; 55(1):75-83. PubMed ID: 23455837 [TBL] [Abstract][Full Text] [Related]
14. Plasma exchange in the long-term management of Waldenström's macroglobulinemia. Buskard NA; Galton DA; Goldman JM; Kohner EM; Grindle CF; Newman DL; Twinn KW; Lowenthal RM Can Med Assoc J; 1977 Jul; 117(2):135-7. PubMed ID: 406031 [TBL] [Abstract][Full Text] [Related]